Endoscopic Retrograde Cholangiopancreatography Market - Forecast(2022 - 2027)

Report Code: HCR 64638 Report Format: PDF + Excel

Endoscopic Retrograde Cholangiopancreatography Market Overview

Endoscopic Retrograde Cholangiopancreatography Market size is estimated to reach $1.9 billion by 2027, growing at a CAGR of 5.4% during the forecast period 2022-2027. Endoscopic Retrograde Cholangiopancreatography (ERCP) integrates endoscopy and x-rays to analyze and treat conditions of the bile and pancreatic ducts. Application of precut sphincterotomy at the time of endoscopic retrograde cholangiopancreatography (ERCP) may boost the odds for cannulation success but is related to raised hazard of post-ERCP pancreatitis. Earlier, rather than deferred, the application of precut sphincterotomy involving spincterotomes for cases with challenging biliary access may minimize this hazard. Ogilvie syndrome is the intense dilation of the colon in the absence of any mechanical impediment in seriously sick patients. Esophageal diverticula are categorized by their position within the esophagus. Zenker’s diverticula are the most typical kind of diverticula of the esophagus. Endoscopic retrograde cholangiopancreatography (ERCP) is a significant instrument for the diagnosis and treatment of the hepatobiliary system. The application of fluoroscopy to assist ERCP positions both the patient and the endoscopy staff at the hazard of radiation-induced harm. Magnetic resonance cholangiopancreatography (MRCP) is a novel non-intrusive modality that demonstrates liquid in the biliary and pancreatic ducts in an axial or three-dimensional image format, somewhat worthy of comparison in appearance and diagnostic precision to radiographic methods observed with direct contrast endoscopic retrograde cholangiopancreatography (ERCP). The increasing predominance of gastrointestinal and incessant biliary ailments like Barrett’s disease is set to drive the Endoscopic Retrograde Cholangiopancreatography Market. The expanding population of the elderly and enhanced awareness regarding Endoscopic Retrograde Cholangiopancreatography devices like sphincterotomes are set to propel the growth of the Endoscopic Retrograde Cholangiopancreatography Market during the forecast period 2022-2027. This represents the Endoscopic Retrograde Cholangiopancreatography Industry Outlook.

Report Coverage

The report: Endoscopic Retrograde Cholangiopancreatography Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Endoscopic Retrograde Cholangiopancreatography Market.

By Product Type: Endoscopes, Endotherapy Devices, Spincterotome, Lithotripter, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others.
By Application:
Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stenting.
By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Laboratories, Others.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

  • Geographically, North America Endoscopic Retrograde Cholangiopancreatography Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the soaring expenditure for R&D and well-entrenched healthcare infrastructure including sphincterotomes in the North American region.
  • Endoscopic Retrograde Cholangiopancreatography Market growth is being driven by the surging significance and acceptance of Endoscopic retrograde cholangiopancreatography (ERCP) devices like sphincterotomes for accumulating samples of tissue or to treat an obstructed pancreatic or bile duct. However, the rigorous isolation, contamination curbing standards and the rigid adherence to application of personal protective equipment (PPE) in the wake of the COVID-19 pandemic is one of the major factors hampering the growth of Endoscopic Retrograde Cholangiopancreatography Market.
  • Endoscopic Retrograde Cholangiopancreatography Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Endoscopic Retrograde Cholangiopancreatography Market report.

    Endoscopic Retrograde Cholangiopancreatography Market: Market Share (%) by Region, 2021


    For More Details on This Report - Request for Sample

Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis – By Product Type:

The Endoscopic Retrograde Cholangiopancreatography Market based on product type can be further segmented into Endoscopes, Endotherapy Devices, Spincterotome, Lithotripter, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, and Others. The Spincterotome Segment held the largest market share in 2021. This growth is owing to the surging application of sphincterotomes to expedite efficient cannulation. The Dreamtome RX Cannulating Sphincterotome is preloaded with a Dreamwire™ High Performance Guidewire to promote effective cannulation. The expanded research related to the increasing population of the elderly worldwide and the proliferating financing for the establishment of surgical tools is further propelling the growth of the Spincterotome segment.

Furthermore, the Endotherapy Devices segment is estimated to grow with the fastest CAGR of 5.9% during the forecast period 2022-2027 owing to the soaring demand for Endoscopic Retrograde Cholangiopancreatography (ERCP) therapeutics processes and the increasing predominance of choledocholithiasis, gall bladder stones, pancreatitis, and other bile duct and pancreatic duct ailments which may require the application of sphincterotomes.

Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis – By End User:

The Endoscopic Retrograde Cholangiopancreatography Market based on end-user can be further segmented into Hospitals And Clinics, Ambulatory Surgical Centers, Laboratories, and Others. The Hospitals And Clinics segment held the largest market share in 2021. This growth is owing to the accelerated growth of healthcare infrastructure in the North-American and European regions which have assisted in the financial development of hospitals. The surging demand by patients for treatment in hospitals involving devices like sphincterotomes and superior preventive care and enhanced treatment options in clinics are further propelling the growth of this segment.

Furthermore, the Ambulatory Surgical Centers segment is estimated to grow with the fastest CAGR of 6.1% during the forecast period 2022-2027 owing to the lower time needed for endoscopy and the accelerated recovery time which are backing the demand for endoscopic interferences or surgeries in the ambulatory surgical centers which may involve the application of sphincterotomes in conjunction with the minimized hospital stay resulting in reduced complete costs, further propelling the demand for surgical processes at ambulatory surgical centers.

Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis – By Geography:

The Endoscopic Retrograde Cholangiopancreatography Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Endoscopic Retrograde Cholangiopancreatography Market) held the largest share with 35% of the overall market in 2021. The growth of this region is owing to the extensive research associated with diagnostic imaging and the soaring establishment of technologically progressive ERCP instruments like sphincterotomes in the region. The boost in the government financing for healthcare and the existence of key players like Hobbs Medical Inc., in the region are further propelling the growth of the Endoscopic Retrograde Cholangiopancreatography Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors development of the healthcare sector. The surging awareness regarding the treatment of pancreatic and liver ailments involving spincterotomes is further fuelling the progress of the Endoscopic Retrograde Cholangiopancreatography Market in the Asia-Pacific region.

Endoscopic Retrograde Cholangiopancreatography Market Drivers

Increased Application Of Endoscopic Retrograde Cholangiopancreatography Is Projected To Drive The Growth Of Endoscopic Retrograde Cholangiopancreatography Market:

Endoscopic retrograde cholangiopancreatography, or ERCP, is a technique to diagnose and treat issues in the liver, gallbladder, bile ducts, and pancreas. Endoscopic retrograde cholangiopancreatography (ERCP) is a method that utilizes an integration of luminal endoscopy and imaging based on fluoroscopy to diagnose and treat conditions related to the pancreatobiliary system. It integrates X-ray and the application of an endoscope—a lengthy, malleable, lighted tube. ERCP may be utilized to discover the cause of undiscovered abdominal pain or yellowing of the skin and eyes (jaundice). It can be utilized to acquire more information if there is pancreatitis or cancer of the liver, pancreas, or bile ducts. Additional conditions that can be discovered with Endoscopic Retrograde Cholangiopancreatography (ERCP) are inclusive of obstructions or stones in the bile ducts and liquid drainage from the bile or pancreatic ducts. Obstructions or restrictions of the pancreatic ducts, tumorx and contamination in the bile ducts are certain other conditions that may be discovered with an ERCP. and this is fuelling the growth of the Endoscopic Retrograde Cholangiopancreatography Market during the forecast period 2022-2027.

Novel Products Are Expected To Boost The Demand Of Endoscopic Retrograde Cholangiopancreatography:

CONMED Corporation has developed a sphincterotomes termed TruPass® Triple Lumen Papillotomes. These are compatible with short-wire ERCP methods. CONMED’s TruPass® SW Papillotomes are planned to transfer approved orientation and presently have one of the littlest tips of any .035” guidewire compatible triple lumen papillotomes accessible. The characteristics and advantages include planned to transfer approved orientation, discernible short wire compatible entry ramp, color-coded cutting wire markers, and streamlined, atraumatic radiopaque tip. There is also FIT® Stone Balloon for the elimination of stones. Planned by endoscopists for endoscopists, CONMED’s FIT® (Flexible Intelligent Therapy) SW Stone Balloon adapts to the duct size to guarantee the effortless elimination of biliary stones. The FIT® Biliary Stone Balloon increases to series from 9mm up to 22mm minimizing the requirement to alter instrument. These kinds of novel products are driving the growth of the Endoscopic Retrograde Cholangiopancreatography Market during the forecast period 2022-2027.

Endoscopic Retrograde Cholangiopancreatography Market Challenges

Challenges Of Endoscopic Retrograde Cholangiopancreatography In Patients With Billroth II Gastrointestinal Anatomy Presents Challenges To The Growth Of The Endoscopic Retrograde Cholangiopancreatography Market:

Endoscopic retrograde cholangiopancreatography (ERCP) is an integration of endoscopy and fluoroscopy that is typically utilized in the handling of pancreaticobiliary ailments. ERCP may be demanding if carried out in surgically changed anatomy, like a Billroth II reorganization, in comparison with native anatomy and normally has a decreased success rate. Five rising challenges were recognized in such patients. These are the selection of endoscope, the recognition of afferent loop, arriving at the duodenal stump, cannulation in the reverse position, and endoscopic sphincterotomy. Carrying out ERCP in patients with a Billroth II reorganization requires sufficient expertise, suitable skill, and knowledge to accomplish a good clinical result. These issues are hampering the growth of the Endoscopic Retrograde Cholangiopancreatography Market.

Endoscopic Retrograde Cholangiopancreatography Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in this market. Endoscopic Retrograde Cholangiopancreatography top 10 companies include:

  1. Olympus Corporation
  2. Conmed Corporation
  3. Hobbs Medical, Inc.
  4. TeleMed Systems, Inc.
  5. Boston Scientific Corporation
  6. Cook Group Incorporation
  7. Ambu, Inc.
  8. Fujifilm Holding Corporation
  9. Medtronic Plc
  10. Medi-Globe GmbH

Acquisitions/Product Launches:

Related Reports:

Endoscopy Devices Market
Report Code: HCR 91536

Endoscopy Equipment Market
Report Code: HCR 0563

For more Lifesciences and Healthcare Market reports, please click here

1. Endoscopic Retrograde Cholangiopancreatography Market Overview
    1.1 Definitions and Scope
2. Endoscopic Retrograde Cholangiopancreatography Market - Executive Summary
3. Endoscopic Retrograde Cholangiopancreatography Market– Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis 
4. Endoscopic Retrograde Cholangiopancreatography Market– Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Endoscopic Retrograde Cholangiopancreatography Market– Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Endoscopic Retrograde Cholangiopancreatography Market- Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Endoscopic Retrograde Cholangiopancreatography Market– By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Endoscopic Retrograde Cholangiopancreatography Market - By Product Type (Market Size –$Million/$Billion) 
    8.1 Endoscopes
    8.2 Endotherapy Devices
    8.3 Sphincterotome
    8.4 Lithotripter
    8.5 Stents
    8.6 Cannulas
    8.7 Forceps
    8.8 Snares
    8.9 Catheters
    8.10 Guiding Wires
    8.11 Balloons
    8.12 Baskets
    8.13 Others
9. Endoscopic Retrograde Cholangiopancreatography Market - By Application (Market Size –$Million/$Billion) 
    9.1 Biliary Sphincterotomy
    9.2 Biliary Dilatation
    9.3 Biliary Stenting
    9.4 Pancreatic Sphincterotomy
    9.5 Pancreatic Duct Dilatation
    9.6 Pancreatic Duct Stenting
10. Endoscopic Retrograde Cholangiopancreatography Market - By End User (Market Size –$Million/$Billion) 
    10.1 Hospitals And Clinics
    10.2 Ambulatory Surgical Centers
    10.3 Laboratories
    10.4 Others
11. Endoscopic Retrograde Cholangiopancreatography Market- By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest Of The World
        11.5.1 Middle East
        11.5.2 Africa
12. Endoscopic Retrograde Cholangiopancreatography Market- Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs, and partnerships
13. Endoscopic Retrograde Cholangiopancreatography Market– Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Endoscopic Retrograde Cholangiopancreatography Market– Key Company List by Country Premium (Premium)
15. Endoscopic Retrograde Cholangiopancreatography Market- Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"

LIST OF TABLES

1.Global Global Endoscopic Retrograde Cholangiopancreatography Market, By End User Market 2019-2024 ($M)
1.1 Hospital Market 2019-2024 ($M) - Global Industry Research
1.2 Clinic Market 2019-2024 ($M) - Global Industry Research
2.Global Global Endoscopic Retrograde Cholangiopancreatography Market, By End User Market 2019-2024 (Volume/Units)
2.1 Hospital Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 Clinic Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America Global Endoscopic Retrograde Cholangiopancreatography Market, By End User Market 2019-2024 ($M)
3.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
3.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
4.South America Global Endoscopic Retrograde Cholangiopancreatography Market, By End User Market 2019-2024 ($M)
4.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
4.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
5.Europe Global Endoscopic Retrograde Cholangiopancreatography Market, By End User Market 2019-2024 ($M)
5.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
5.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
6.APAC Global Endoscopic Retrograde Cholangiopancreatography Market, By End User Market 2019-2024 ($M)
6.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
6.2 Clinic Market 2019-2024 ($M) - Regional Industry Research
7.MENA Global Endoscopic Retrograde Cholangiopancreatography Market, By End User Market 2019-2024 ($M)
7.1 Hospital Market 2019-2024 ($M) - Regional Industry Research
7.2 Clinic Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
2.Canada Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
3.Mexico Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
4.Brazil Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
5.Argentina Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
6.Peru Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
7.Colombia Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
8.Chile Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
9.Rest of South America Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
10.UK Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
11.Germany Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
12.France Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
13.Italy Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
14.Spain Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
15.Rest of Europe Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
16.China Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
17.India Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
18.Japan Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
19.South Korea Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
20.South Africa Endoscopic Retrograde Cholangiopancreatography Market Revenue, 2019-2024 ($M)
21.North America Endoscopic Retrograde Cholangiopancreatography By Application
22.South America Endoscopic Retrograde Cholangiopancreatography By Application
23.Europe Endoscopic Retrograde Cholangiopancreatography By Application
24.APAC Endoscopic Retrograde Cholangiopancreatography By Application
25.MENA Endoscopic Retrograde Cholangiopancreatography By Application
26.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Boston Scientific Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Medtronic Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Conmed Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Stryker Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Fujifilm Holding Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Ethicon Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Becton, Dickinson And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.B. Braun Melsungen Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Cook Group Incorporated, Sales /Revenue, 2015-2018 ($Mn/$Bn)